Presentation Icons

Surgery Day

Bench-to-Bedside

SIU@U

Debate: Immune checkpoint blockade plus BCG is the new standard first-line therapy for high-risk NMIBC

Session: 7th B2B Uro-Oncology: GU Cancers Triad Meeting - BLADDER CANCER

B2B-01: Pro

Friday, October 31, 2025

10:05 - 10:13 GMT+0

Speaker(s)

Kilian Martin Gust

Medical University of Vienna, Department of Urology
Austria, Austria